First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist,...

  • Main
  • 2020 / 03
  • First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist,...

First-in-Human Study of Utomilumab, a 4-1BB/CD137 Agonist, in Combination with Rituximab in Patients with Follicular and Other CD20 + Non-Hodgkin Lymphomas

Gopal, Ajay K., Levy, Ronald, Houot, Roch, Patel, Sandip P., Popplewell, Leslie, Jacobson, Caron, Mu, Xinmeng J., Deng, Shibing, Ching, Keith A., Chen, Ying, Davis, Craig B., Huang, Bo, Fly, Kolette D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-19-2973
Date:
March, 2020
File:
PDF, 1.09 MB
2020
Conversion to is in progress
Conversion to is failed